Asia-Pacific Fluoroscopy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

Asia-Pacific Fluoroscopy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

The Asia-Pacific Fluoroscopy Market size is estimated at USD 1.21 billion in 2024, and is expected to reach USD 1.56 billion by 2029, growing at a CAGR of 5.11% during the forecast period (2024-2029).

Fluoroscopy devices market is primarily driven by rising demand for minimally-invasive surgeries, growing geriatric population, the prevalence of chronic diseases, and increasing use of fluoroscopy in pain management.

Medical imaging has applications at various stages of inpatient management processes, such as diagnosis, staging, therapy delivery, and its follow-ups. The primary role for imaging has been diagnostics, but it is increasing slowly for interventional diagnostics and therapeutic uses that are driven by minimally-invasive procedures. Fluoroscopy presents real-time moving images for the diagnostic evaluation of soft and hard tissue conditions. It is an indispensable tool for many interventional medical procedures. The fluoroscopy market is anticipated to register significant growth, with an increasing number of minimally-invasive surgeries that are of high-precision, including the devices used, resulting in better support for both patients and surgeons. In December 2017, Hologic Inc. introduced Fluoroscan InSight FD Mini C-Arm extremities imaging system at the 2017 Radiological Society of Asia-Pacific (RSNA) annual conference in Chicago. The advancemnets in the products and new roduct launches in teh region is also boosting the market. However, the side effects associated with radiation is expected to hinder the market growth over the forecast period.

APAC Fluoroscopy Market Trends

The Cardiovascular Segment, under Application, is Expected to Account for the Largest Market Share, during the Forecast Period

Cardiovascular procedures require extensive fluoroscopic guidance to navigate endovascular catheters. The fluoroscopy provides excellent spatial and temporal resolution, having a limitation of exposure of ionizing radiation to the patients and staff, along with poor soft tissue characterization. In the process of cardiac catheterization, fluoroscopy is used to help the healthcare provider see the flow of blood through the coronary arteries to check for arterial blockages. Therefore, the rising prevalence of cardiovascular diseases across the region is a major factor driving the growth of the market. According to self-reported data from the Australian Bureau of Statistics (ABS) 2017-18 National Health Survey, an estimated 1.2 million Australian adults aged 18 years and over had one or more conditions related to the heart or vascular disease, including stroke for the year 2017-2018. Thus, owing to the rising prevalence of cardiac diseases and benefits associated with fluoroscopy, the market is expected to grow over the forecast period.

APAC Fluoroscopy Industry Overview

The Asia-Pacific Fluoroscopy Market is moderately competitive with several major players. Some of the strategies implemented include agreements, collaborative models, business expansion, and product developments. Some of the major players Merck KGaA, Thermo Fisher Scientific, GE Healthcare, Sovicell GMBH, Absorption Systems , Eurofins Scientific, ADMEcell, Inc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support